TSH Biopharm Corporation Limited

TPEX:8432 Stock Report

Market Cap: NT$2.3b

TSH Biopharm Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Sze-Yuan Yang

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure5.3yrs
CEO ownershipn/a
Management average tenure4yrs
Board average tenure3.9yrs

Recent management updates

Recent updates

Weak Financial Prospects Seem To Be Dragging Down TSH Biopharm Corporation Limited (GTSM:8432) Stock

Feb 18
Weak Financial Prospects Seem To Be Dragging Down TSH Biopharm Corporation Limited (GTSM:8432) Stock

Is TSH Biopharm Corporation Limited (GTSM:8432) An Attractive Dividend Stock?

Jan 21
Is TSH Biopharm Corporation Limited (GTSM:8432) An Attractive Dividend Stock?

TSH Biopharm's (GTSM:8432) Shareholders Are Down 26% On Their Shares

Dec 16
TSH Biopharm's (GTSM:8432) Shareholders Are Down 26% On Their Shares

CEO Compensation Analysis

How has Sze-Yuan Yang's remuneration changed compared to TSH Biopharm's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023n/an/a

NT$62m

Sep 30 2023n/an/a

NT$54m

Jun 30 2023n/an/a

NT$55m

Mar 31 2023n/an/a

NT$53m

Dec 31 2022n/an/a

NT$62m

Sep 30 2022n/an/a

NT$68m

Jun 30 2022n/an/a

NT$60m

Mar 31 2022n/an/a

NT$57m

Dec 31 2021NT$6mNT$4m

NT$47m

Sep 30 2021n/an/a

NT$47m

Jun 30 2021n/an/a

NT$53m

Mar 31 2021n/an/a

NT$48m

Dec 31 2020NT$6mNT$5m

NT$62m

Compensation vs Market: Insufficient data to establish whether Sze-Yuan's total compensation is reasonable compared to companies of similar size in the TW market.

Compensation vs Earnings: Sze-Yuan's compensation has been consistent with company performance over the past year.


CEO

Sze-Yuan Yang

5.3yrs

Tenure

NT$5,724,000

Compensation

Ms. Sze-Yuan Yang serves as General Manager at TSH Biopharm Corporation Limited since January 17, 2019. She studied at Institute of Pharmacology, National Yangming University. She has served at TTY Pharmac...


Leadership Team

NamePositionTenureCompensationOwnership
Sze-Yuan Yang
General Manager5.3yrsNT$5.72mno data
Xin-Yang Liu
Vice General Manager of General Administration4yrsNT$3.07mno data
Jung-Liang Kao
Chief Financial Officerno datano datano data
Chen-Ju Kan
Senior Manager of the Accounting Departmentno datano datano data
Jian-Rong Huang
Sales Division Director4yrsno datano data
Hsin-Young Liu
Company Secretary3.9yrsno datano data

4.0yrs

Average Tenure

Experienced Management: 8432's management team is considered experienced (4 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Chuan-Quan Lin
Chairman3.9yrsno datano data
Kang-Chi Chou
Representative Director3.9yrsno datano data
Carl Hsiao
Representative Director3.9yrsno datano data
Rwei-Syun Chen
Independent Directorno datano datano data
Yaw-Bin Huang
Independent Directorno datano datano data
Te-Yu Chou
Independent Directorless than a yearno datano data
Yong-Liang Wu
Directorless than a yearno datano data

3.9yrs

Average Tenure

Experienced Board: 8432's board of directors are considered experienced (3.9 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.